官方服务：
资源简介：
CI: Confidence interval. HR: Hazard ratio.
应用场景：
创建时间：
2015-12-02
相关数据集
Supplementary Material for: Assessment of Losartan 50 mg on Survival of Post-Dialysis Euvolemic Hypertensive Patients: Findings from HELD Trial
Aims and objective: To estimate the effect of losartan 50 mg on survival of post-dialysis euvolemic hypertensive patients. Methodology: A single center, prospective, single
DataCite Commons2020-08-26 更新60
Survival analyses for breast cancer mortality by reported exercise level.
*Adjusted for follow-up age (age, age2), race, menopause, and oral contraceptive and estrogen or estrogen/progesterone use. Additional adjustment for BMI as indicated.
Figshare2015-12-02 更新00
Direct effects (beta) of patient, cancer and treatment characteristics on the hazard.
Direct effects (beta) of patient, cancer and treatment characteristics on the hazard.
Figshare2016-12-20 更新00
Neoadjuvant letrozole for postmenopausal estrogen receptor-positive, HER2-negative breast cancer patients, a study from the Danish Breast Cancer Cooperative Group (DBCG)
Introduction: Neoadjuvant endocrine treatment (NET) is a low-toxicity approach to achieve operability in locally advanced breast cancer, and to facilitate breast conservation in early breast ca
Taylor & Francis Group2018-01-06 更新00
Datasheet1_Pitfalls in time-to-event analysis of registry data: a tutorial based on simulated and real cases.docx
Survival analysis (also referred to as time-to-event analysis) is the study of the time elapsed from a starting date to some event of interest. In practice, these analyses can be challenging and, if m
NIAID Data Ecosystem00
